Cargando…
Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac(®)) in a Rodent Model
Background: Inhaled chemotherapeutics may enhance pulmonary drug exposure to malignant lesions in the lung without substantially contributing to systemic toxicities. The pharmacokinetic profile of inhaled submicron particle paclitaxel (NanoPac(®)) in healthy rodent plasma and lung tissue is evaluate...
Autores principales: | Verco, James, Johnston, William, Baltezor, Michael, Kuehl, Philip J., Gigliotti, Andrew, Belinsky, Steven A., Lopez, Anita, Wolff, Ronald, Hylle, Lauren, diZerega, Gere |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477588/ https://www.ncbi.nlm.nih.gov/pubmed/30359162 http://dx.doi.org/10.1089/jamp.2018.1467 |
Ejemplares similares
-
Inhaled Submicron Particle Paclitaxel (NanoPac) Induces Tumor Regression and Immune Cell Infiltration in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer
por: Verco, James, et al.
Publicado: (2019) -
Local administration of submicron particle paclitaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects without local or systemic toxicity: preclinical and clinical studies
por: Verco, Shelagh, et al.
Publicado: (2020) -
Local administration of large surface area microparticle docetaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects: preclinical and clinical studies
por: Maulhardt, Holly, et al.
Publicado: (2022) -
Early phase trial of intracystic injection of large surface area microparticle paclitaxel for treatment of mucinous pancreatic cysts
por: Othman, Mohamed, et al.
Publicado: (2022) -
Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts
por: Maulhardt, Holly A., et al.
Publicado: (2019)